Published in N Engl J Med on February 15, 1973
Colonoscopy. Gut (1973) 1.62
A new approach to colonic polyps. Ann Surg (1973) 1.15
Sufficiency of clinical literature on the appropriate uses of six medical and surgical procedures. West J Med (1987) 0.95
Polypoid lesions of the proximal colon: comparison of experiences with removal at laparotomy and by colonoscopy. Ann Surg (1974) 0.79
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation (1989) 6.87
Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med (1993) 5.19
Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med (1984) 3.70
Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med (1997) 3.13
Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion. Radiology (1993) 3.07
Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest (1995) 2.95
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med (1992) 2.63
Daily regimen and compliance with treatment. BMJ (2001) 2.61
Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. N Engl J Med (1991) 2.46
Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology (1990) 2.14
Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest (1996) 2.14
Clinical uses of low-molecular-weight heparins. Chest (1999) 2.05
Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol (1996) 2.01
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med (1999) 1.96
Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med (1995) 1.89
Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation. Chest (1998) 1.81
Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA (1995) 1.78
Preoperative laparoscopy in diagnosis of acute abdominal pain. Lancet (1975) 1.78
Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet (1996) 1.78
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost (2014) 1.74
Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol (1998) 1.69
Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest (1994) 1.64
Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. A light, electron microscopic and immunohistochemical study. Lab Invest (1989) 1.64
Cultured epithelial autografts for giant congenital nevi. Plast Reconstr Surg (1989) 1.63
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost (2006) 1.62
Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am J Med (1982) 1.56
End results, cost and productivity of coronary-care units. N Engl J Med (1973) 1.53
Acute hemodilution: its effect of hemodynamics and oxygen transport in anesthetized man. Ann Surg (1974) 1.52
Home and hospital cost of terminal illness. Med Care (1980) 1.49
Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Arch Intern Med (1992) 1.49
Doctors who perform operations. A study on in-hospital surgery in four diverse geographic areas (first of two parts). N Engl J Med (1976) 1.48
Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation (2001) 1.46
Pulmonary embolism presenting as seizures. Chest (1997) 1.46
Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism. Chest (1998) 1.45
Lung scan evaluation of thrombolytic therapy for pulmonary embolism. J Nucl Med (1995) 1.44
Doctors who perform operations. A study on in-hospital surgery in four diverse geographic areas (second of two parts). N Engl J Med (1976) 1.44
Pulse-spray thrombolysis: the "careful analysis". Radiology (1994) 1.42
Stretching ideology to the utmost: Marxism and medical technology. Am J Public Health (1979) 1.42
Health and medical care for the elderly and aged population: the state of the evidence. J Am Geriatr Soc (1980) 1.39
Physical exercise and reduced risk of nonfatal myocardial infarction. Am J Epidemiol (1995) 1.37
Issues in the cross-national assessment of health technology. Int J Technol Assess Health Care (1992) 1.36
An overview of contemporary etiologies of congestive heart failure. Am Heart J (1991) 1.36
The epidemiology of disease expenses. The costs of caring for children with cancer. JAMA (1985) 1.35
Diffusion of laparoscopic cholecystectomy among general surgeons in the United States. Med Care (1995) 1.31
Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J (1995) 1.30
Risk factors for pulmonary embolism. The Framingham Study. Am J Med (1983) 1.28
Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest (1997) 1.27
Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol (1997) 1.25
Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med (1990) 1.25
Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation (1995) 1.24
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. J Thromb Haemost (2009) 1.22
Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation (1992) 1.20
Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials. N Engl J Med (1982) 1.15
Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. Arch Surg (1982) 1.14
A free-floating approach to filters. Arch Intern Med (1997) 1.08
Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. Arch Intern Med (1989) 1.07
The perils of D-dimer in the medical intensive care unit. Crit Care Med (2000) 1.07
Acute pulmonary embolism treated with tissue plasminogen activator. Lancet (1986) 1.06
Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med (1984) 1.06
Endocarditis with the indwelling balloon-tipped pulmonary artery catheter in burn patients. J Trauma (1978) 1.06
Prevention and treatment of venous thromboembolism--International Consensus Statement. Int Angiol (2013) 1.01
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest (1992) 1.01
Cancer and venous thromboembolism. Am Heart J (1996) 1.01
Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med (1997) 1.00
Suppressive serum, suppressor lymphocytes, and death from burns. Ann Surg (1981) 1.00
The effects of glucagon on protein metabolism in normal man. Surgery (1979) 1.00
Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarction. Am J Cardiol (1992) 0.99
Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism. Am Heart J (1994) 0.98
Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost (2014) 0.97
Response of the lung to six to 12 hours of 100 per cent oxygen inhalation in normal man. N Engl J Med (1970) 0.97
Chronic venous insufficiency: mechanisms and management. Am Heart J (1996) 0.96
Acute pulmonary embolism treated with thrombolytic agents: current status of tPA and future implications for emergency medicine. Ann Emerg Med (1988) 0.96
Clinically significant venous thromboembolism after gynecologic surgery. J Reprod Med (1999) 0.96
Recovery of regional right ventricular function after thrombolysis for pulmonary embolism. Am J Cardiol (1999) 0.96
Biochemical markers of compliance in the Physicians' Health Study. Am J Prev Med (1991) 0.95
Ovarian vein thrombosis. Am Heart J (1993) 0.95
Surgeons in the United States. Activities, output and income. JAMA (1976) 0.94
Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J (1997) 0.92
The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study. Am Heart J (1991) 0.92
Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts. Am Heart J (1991) 0.91
Radiation therapy in New Hampshire, Massachusetts and Rhode Island. Output and cost. N Engl J Med (1972) 0.91
Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. Chest (2000) 0.90
Cost effects of restricting cost-effective therapy. Med Care (1985) 0.90
Cardiovascular effects of potential occupational hazards. J Am Coll Cardiol (1983) 0.89
Constrictive pericarditis: a case requiring pericardiectomy following Dressler's postmyocardial infarction syndrome. J Thorac Cardiovasc Surg (1981) 0.89
Inosine: a protective agent in an organ culture model of myocardial ischemia. Circ Res (1982) 0.89
A simple technique for detecting small defects of the atrial septum. Am J Cardiol (1971) 0.89
Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group. Arch Intern Med (1998) 0.89
Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J Thromb Haemost (2006) 0.88
Time trends in hospital mortality and diagnosis of pulmonary embolism. Am Heart J (1982) 0.87
Cultured human sole-derived keratinocyte grafts re-express site-specific differentiation after transplantation. Differentiation (1998) 0.87
Crystalloid versus colloid hemodilution in man. Surg Gynecol Obstet (1976) 0.87
Evaluation of long-functioning human kidney transplants. Surg Gynecol Obstet (1967) 0.86
Cardiovascular risk stratification of pulmonary embolism. Am J Cardiol (1996) 0.86
Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. J Am Coll Cardiol (1987) 0.86
Acute normovolemic hemodilution with crystalloid vs colloid replacement. Surg Forum (1974) 0.86
Rapid estimation of pulmonary extravascular water with an instream catheter. J Appl Physiol (1975) 0.86
Multi-screen electronic alerts to augment venous thromboembolism prophylaxis. Thromb Haemost (2009) 0.86